TYRUKO
NDC 61314-543, natalizumab-sztn, injection, from Sandoz Inc.
- Product NDC
- 61314-543
- Status
- Listed
- Labeler
- Sandoz Inc
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761322
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61314-543 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NATALIZUMAB300 mg/15mL
Pharmacologic classes
Integrin Receptor Antagonist [EPC]; Integrin Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61314-543-94 | 61314054394 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61314-543-94) / 15 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ef653c36-dd4b-4e71-9d2d-40b8fea24b67Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=61314-543
Use it
Look up 61314-543 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61314-543 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61314-543. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.